These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28889108)

  • 1. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.
    Tanash HA; Ekström M; Rönmark E; Lindberg A; Piitulainen E
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ).
    Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
    Thorax; 2008 Dec; 63(12):1091-5. PubMed ID: 18682522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.
    Tanash H; Ekström M; Basil N; Rönmark E; Lindberg A; Piitulainen E
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1245-1252. PubMed ID: 32606637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
    Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in severe alpha-1-antitrypsin deficiency (PiZZ).
    Tanash HA; Nilsson PM; Nilsson JA; Piitulainen E
    Respir Res; 2010 Apr; 11(1):44. PubMed ID: 20420704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden.
    Tanash HA; Ekström M; Wagner P; Piitulainen E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1663-9. PubMed ID: 27555756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
    Bernspång E; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
    Piitulainen E; Tanash HA
    COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years.
    Mostafavi B; Piitulainen E; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():525-530. PubMed ID: 30880942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
    Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
    COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Eriksson S
    Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
    Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
    Piitulainen E; Sveger T
    Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema.
    Tanash HA; Riise GC; Hansson L; Nilsson PM; Piitulainen E
    J Heart Lung Transplant; 2011 Dec; 30(12):1342-7. PubMed ID: 21821433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
    Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.